ArticleArchives of women's mental health2024

FDA approved fezolinetant (Veozah): a critical evaluation of its efficacy and safety for menopausal vasomotor symptoms, calling for prospective research.

Priya Rani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.